Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,459 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Asthma Exacerbation Study

NCT01086384

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Oxford, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 183 locations
View Trial Details
Completed

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

NCT01000506

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 94 locations
View Trial Details
Completed

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

NCT00398645

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Fullerton, California, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Orange, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 82 locations
View Trial Details
Completed

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)

NCT00200967

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • National Jewish Medical & Research Center Denver, Colorado, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

NCT02649478

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Roxane Laboratories Research Site #30 Glendale, Arizona, United States
  • Roxane Laboratories Research Site #46 Phoenix, Arizona, United States
  • Roxane Laboratories Research Site #1 Surprise, Arizona, United States
  • Roxane Laboratories Research Site #13 Tempe, Arizona, United States
View all 100 locations
View Trial Details

Related conditions